<SEC-DOCUMENT>0001903596-24-000275.txt : 20240507
<SEC-HEADER>0001903596-24-000275.hdr.sgml : 20240507
<ACCEPTANCE-DATETIME>20240506211741
ACCESSION NUMBER:		0001903596-24-000275
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20240507
DATE AS OF CHANGE:		20240506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Expion360 Inc.
		CENTRAL INDEX KEY:			0001894954
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				812701049
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272956
		FILM NUMBER:		24919312

	BUSINESS ADDRESS:	
		STREET 1:		2025 SW DEERHOUND AVE
		CITY:			REDMOND
		STATE:			OR
		ZIP:			97756
		BUSINESS PHONE:		541 -797-6714

	MAIL ADDRESS:	
		STREET 1:		2025 SW DEERHOUND AVE
		CITY:			REDMOND
		STATE:			OR
		ZIP:			97756
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>xpon_424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Registration No. 333-272956</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>(To Prospectus dated July 10, 2023)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPION360 INC.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>100,000 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are offering 100,000 shares of our common stock,
par value $0.001 per share (&ldquo;Common Stock&rdquo;), pursuant to this prospectus supplement, the accompanying base prospectus and
that certain Settlement and Mutual Release Agreement, dated May 2, 2024 (the &ldquo;Settlement Agreement&rdquo;), by and between us and
Alexander Capital L.P. (&ldquo;Alexander&rdquo;). The shares are being issued in consideration of the amount payable under the terms of
the Settlement Agreement, and accordingly, no cash proceeds will be received by us from the issuance of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock is listed on The Nasdaq Capital Market
(&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;XPON.&rdquo; On May 6, 2024, the last reported sale price of our Common Stock on Nasdaq
was $1.88 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">As of May 1, 2024, the aggregate market
value of our outstanding common stock held by non-affiliates, or public float, was approximately $20.6 million. This value was computed
by reference to the highest closing price of our common stock on the Nasdaq Capital Market within the preceding 60 days ($3.604 per share
on March 7, 2024) multiplied by 5,715,926 shares held by non-affiliates. Pursuant to General Instruction I.B.6 of Form S-3, in no event
will we sell securities in a public primary offering with a value exceeding one-third of our&nbsp;public float in any 12-month period
so long as our&nbsp;public float remains below $75.0 million. During the 12 calendar months prior to and including the date of this prospectus
supplement (excluding this offering), we have sold $1,989,429 in securities pursuant to General Instruction I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are an &ldquo;emerging growth company,&rdquo; as
that term is used in the Jumpstart Our Business Startups Act of 2012 and, under applicable Securities and Exchange Commission (&ldquo;SEC&rdquo;)
rules, we have elected to take advantage of certain reduced public company reporting requirements for this prospectus and future filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Investing in our
Common Stock involves a high degree of risk. Refer to the sections entitled &ldquo;<I>Risk Factors</I>&rdquo; beginning on page S-7 of
this prospectus supplement and beginning on page 7 of the accompanying base prospectus for a discussion of information that should be
considered in connection with an investment in our Common Stock.</B></FONT><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Neither the SEC nor any state securities commission
has approved or disapproved of the shares or determined if this prospectus is truthful or complete. Any representation to the contrary
is a criminal offense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Delivery of the shares of Common Stock is expected
on or about May 8, 2024.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>The date of this prospectus supplement is May 7,
2024.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>TABLE OF CONTENTS</B></FONT><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Prospectus Supplement</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 49px; border-bottom: black 1.5pt solid; padding: 0.25pt 0.25pt 0.75pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_001"><FONT STYLE="font-size: 10pt; text-transform: uppercase">ABOUT THIS PROSPECTUS supplement</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">S-1</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_002"><FONT STYLE="font-size: 10pt; text-transform: uppercase">PROSPECTUS supplement SUMMARY</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">S-2</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">S-3</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_004"><FONT STYLE="font-size: 10pt; text-transform: uppercase">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">S-4</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_005"><FONT STYLE="font-size: 10pt; text-transform: uppercase">RISK FACTORS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">S-5</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_006"><FONT STYLE="font-size: 10pt; text-transform: uppercase">DIVIDEND POLICY</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">S-6</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_007"><FONT STYLE="font-size: 10pt; text-transform: uppercase">Use of Proceeds</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">S-7</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">S-7</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt; text-transform: uppercase">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">S-8</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt; text-transform: uppercase">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">S-9</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt; text-transform: uppercase">EXPERTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">S-8</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_012"><FONT STYLE="font-size: 10pt; text-transform: uppercase">WHERE YOU CAN FIND ADDITIONAL INFORMATION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">S-9</FONT></A></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt"><A HREF="#a_013"><FONT STYLE="font-size: 10pt; text-transform: uppercase">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">S-10</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Base Prospectus</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 48px; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_014"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_015"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_016"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_016"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_017"><FONT STYLE="font-size: 10pt">INCORPORATION BY REFERENCE </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">4</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_018"><FONT STYLE="font-size: 10pt">PROSPECTUS SUMMARY </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">5</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_019"><FONT STYLE="font-size: 10pt">RISK FACTORS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_020"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_020"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_021"><FONT STYLE="font-size: 10pt">GENERAL DESCRIPTION OF SECURITIES </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_021"><FONT STYLE="font-size: 10pt">9</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_022"><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_022"><FONT STYLE="font-size: 10pt">10</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_023"><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_023"><FONT STYLE="font-size: 10pt">14</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_024"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_024"><FONT STYLE="font-size: 10pt">22</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><A HREF="#a_025"><FONT STYLE="font-size: 10pt">LEGAL MATTERS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_025"><FONT STYLE="font-size: 10pt">25</FONT></A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_026"><FONT STYLE="font-size: 10pt">EXPERTS </FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_026"><FONT STYLE="font-size: 10pt">26</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_001" TITLE="ABOUT THIS PROSPECTUS SUPPLEMENT"></A>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus supplement and
the accompanying base prospectus are part of a Registration Statement on Form&nbsp;S-3 (File No. 333-272956) that we filed with the SEC
utilizing a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we are offering shares of our Common Stock
in the offering described in this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This document is in two parts.
The first part is this prospectus supplement, which describes the specific terms of the offering and also adds to and updates information
contained in the accompanying base prospectus and the documents incorporated by reference herein and therein. The second part, the accompanying
base prospectus, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this
document combined. To the extent there is a conflict between the information contained in this prospectus supplement and the information
contained in the accompanying base prospectus or any document incorporated by reference herein or therein filed prior to the date of this
prospectus supplement, you should rely on the information in this prospectus supplement; provided that if any statement in one of these
documents is inconsistent with a statement in another document having a later date&mdash;for example, a document incorporated by reference
in the accompanying base prospectus&mdash;the statement in the document having the later date modifies or supersedes the earlier statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You should rely only on the information
contained in this prospectus, or the information incorporated by reference herein. We have not authorized anyone to provide you with information
that is different. The information contained in this prospectus, or incorporated by reference herein, is accurate only as of the respective
dates thereof, regardless of the time of delivery of this prospectus or of any issuance of our shares. It is important that you read and
consider all information contained in this prospectus, including the documents incorporated by reference herein, in making your investment
decision. You should also read and consider the information in the documents to which we have referred you in the sections entitled &ldquo;<I>Where
You Can Find Additional Information</I>&rdquo; and &ldquo;<I>Incorporation of Certain Information by Reference</I>&rdquo; in this prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The representations, warranties
and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference herein were made
solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties
to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties
or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied
on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are offering our shares of
Common Stock offered by this prospectus only in jurisdictions where offers are permitted. The distribution of this prospectus and the
offering of our shares of Common Stock in certain jurisdictions may be restricted by law. Persons outside the United States who come into
possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our shares of Common
Stock and the distribution of this prospectus outside the United States. This prospectus does not constitute, and may not be used in connection
with, an offer to sell, or a solicitation of an offer to buy, any shares of Common Stock offered by this prospectus by any person in any
jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless otherwise mentioned or
unless the context requires otherwise, all references in this prospectus to the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our&rdquo; and &ldquo;Expion360&rdquo; refer to Expion360 Inc., a Nevada corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002" TITLE="PROSPECTUS SUPPLEMENT SUMMARY"></A>PROSPECTUS
SUPPLEMENT SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>This prospectus supplement
summary highlights selected information included elsewhere in the prospectus and does not contain all of the information you should consider
before buying shares of our Common Stock. You should read the entire prospectus carefully, including the section entitled &ldquo;Risk
Factors&rdquo; and the financial statements and related notes incorporated by reference into this prospectus, before deciding to invest
in our Common Stock. Some of the statements in this prospectus supplement constitute forward-looking statements. For additional information,
refer to the section of this prospectus supplement entitled &ldquo;Cautionary Note Regarding Forward-Looking Statements.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt"><B>&nbsp;Overview </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">Expion360 focuses on the
design, assembly, manufacturing, and sales of lithium iron phosphate (&ldquo;LiFePO4&rdquo;) batteries and supporting accessories for
recreational vehicles (&ldquo;RVs&rdquo;), marine applications and home energy storage products, with plans to expand into industrial
applications. We design, assemble, and distribute high-powered, lithium battery solutions using ground-breaking concepts and rugged, high-quality
designs with a creative sales and marketing approach. We believe that our product offerings include some of the most dense and minimal-footprint
batteries in the RV and marine industries. We are developing the e360 Home Energy Storage System, a system that we expect to significantly
change the industry in barrier price, flexibility, and integration. We are deploying multiple intellectual property strategies with cutting-edge
research and unique products to sustain and scale the business. We currently have customers consisting of dealers, wholesalers, private
label customers and original equipment manufacturers who are driving revenue and brand awareness nationally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">Our corporate headquarters
are based in Redmond, Oregon, and our suppliers are based in the United States, Asia, and Europe. We are currently in the process of building
out manufacturing capacity at our corporate headquarters. Our long-term target is to onshore the manufacturing of most of our components
and assemblies, including cell manufacturing, to the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">Our primary target markets
are currently the RV and marine industries. We believe that we are well-positioned to capitalize on the rapid market conversion from lead-acid
to lithium batteries as the primary method of power sourcing in these industries. We are also focused on expanding into the home energy
storage market with the introduction of our two LiFePO4 battery storage systems, where we aim to provide a cost-effective, low barrier
of entry, flexible system for those looking to power their homes via solar energy, wind, or grid back-up. Along with RV, marine and home
energy storage markets, we aim to provide additional capacities to the ever-expanding electric forklift and industrial material handling
markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">Expion360&rsquo;s e360 product
line, which is manufactured for the RV and marine industries, was launched in December 2020. The e360 product line, through its sales
growth, has shown to be a preferred conversion solution for lead-acid batteries. In December 2023, we announced our entrance into the
home energy storge market with our introduction of two LiFePO4 battery storage solutions that enable residential and small business customers
to create their own stable micro-energy grid and lessen the impact of increasing power fluctuations and outages. We believe that our e360
Home Energy Storage System has strong revenue potential with recurring income opportunities for us and our associated sales partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">Our products provide numerous
advantages for various industries that are looking to migrate to lithium-based energy storage. They incorporate detailed-oriented design
and engineering and strong case materials and internal and structural layouts, and are backed by responsive customer service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Expion360 Inc. was initially
organized as a limited liability company under the name Yozamp Products Company, LLC in the State of Oregon on June 16, 2016, We converted
to a Nevada corporation and changed our name to Expion360 Inc. pursuant to articles of conversion filed on November 16, 2021.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_003" TITLE="THE OFFERING"></A>The Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%; padding-right: 4.5pt; padding-left: 3.8pt"><FONT STYLE="font-size: 10pt"><B>Common Stock offered by us</B></FONT></TD>
    <TD STYLE="width: 72%; padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">100,000 shares of Common Stock, at a deemed offering price of $1.88 per share, which is the last reported sale price of our Common Stock on Nasdaq on May 6, 2024.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt"><FONT STYLE="font-size: 10pt"><B>Common Stock outstanding prior to the offering</B></FONT></TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">7,345,261 shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt"><FONT STYLE="font-size: 10pt"><B>Common Stock to be outstanding after the offering</B></FONT></TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">Up to 7,445,261 shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; font-size: 10pt; font-weight: bold">Nasdaq symbol</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">XPON</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; font-size: 10pt; font-weight: bold">Use of proceeds</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">The shares of Common Stock are being issued in consideration of the amount payable under the terms of the Settlement Agreement, and accordingly, no cash proceeds will be received by us from the issuance of the shares. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt"><FONT STYLE="font-size: 10pt"><B>Risk factors</B></FONT></TD>
    <TD STYLE="padding-right: 4.5pt; padding-left: 3.8pt; text-align: justify"><FONT STYLE="font-size: 10pt">Investing in our Common Stock involves a high degree of risk. You should carefully consider the information set forth in the section entitled &ldquo;<I>Risk Factors</I>&rdquo; beginning on page S-7 of this prospectus supplement and beginning on page 7 of the accompanying base prospectus, for a discussion of information that should be considered in connection with an investment in our Common Stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The number of shares of Common
Stock that will be outstanding is based on the 7,345,261 shares outstanding as of May 1, 2024, and excludes the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="width: 89%; padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">78,000 shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of May 1, 2024, at an exercise price of $2.90 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">514,290 shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of May 1, 2024, at an exercise price of $3.32 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">148,005 shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of May 1, 2024, at an exercise price of $9.10 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">25,000 shares of Common Stock issuable upon the exercise of warrants to purchase Common Stock outstanding as of May 1, 2024, at an exercise price of $5.00 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">30,000 shares of Common Stock issuable upon the exercise of options outstanding as of May 1, 2024, which were not issued under a specified plan,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">1,220,051 shares of Common Stock issuable upon the exercise of equity incentive awards outstanding under our 2021 Incentive Award Plan as of May 1, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">551,623 shares of Common Stock available for future issuance under our 2021 Incentive Award Plan as of May 1, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">2,500,000 shares of Common Stock available for future issuance under our 2021 Employee Stock Purchase Plan as of May 1, 2024; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">396,834 shares of Common Stock issuable upon conversion of the principal amount of our unsecured convertible note as of May 1, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated, all
information in this prospectus assumes no exercise of outstanding options or warrants, and no conversion of convertible notes.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_004" TITLE="CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus supplement, the
accompanying base prospectus, and the documents incorporated by reference herein and therein, contain &ldquo;forward-looking statements&rdquo;
within the meaning of the federal securities laws, which statements are subject to considerable risks and uncertainties. These forward-looking
statements are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995.
All statements included or incorporated by reference in this prospectus, other than statements of historical fact, are forward-looking
statements. You can identify forward-looking statements by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;continue&rdquo;
&ldquo;could,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; or the negative of such terms,
or other comparable terminology. Forward-looking statements also include the assumptions underlying or relating to such statements. In
particular, forward-looking statements included or incorporated by reference in this prospectus relate to, among other things, our future
or assumed financial condition, results of operations, liquidity, business forecasts and plans, strategic plans and objectives, and competitive
environment. We caution you that the foregoing list may not include all of the forward-looking statements made in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our forward-looking statements
are based on our management&rsquo;s current assumptions and expectations about future events and trends, which affect or may affect our
business, strategy, operations or financial performance. Although we believe that these forward-looking statements are based upon reasonable
assumptions, they are subject to numerous known and unknown risks and uncertainties and are made in light of information currently available
to us. Our actual financial condition and results could differ materially from those anticipated in these forward-looking statements as
a result of various factors, including those set forth in the section entitled &ldquo;<I>Risk Factors</I>&rdquo; beginning on page S-7
of this prospectus supplement, beginning on page 7 of the accompanying base prospectus, as well as in the other reports we file with the
SEC. You should read this prospectus with the understanding that our actual future results may be materially different from and worse
than what we expect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Moreover, we operate in an evolving
environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to predict all risk
factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination
of factors, may cause actual results to differ materially from those contained in any forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Forward-looking statements speak
only as of the date they were made, and, except to the extent required by law or the Nasdaq listing rules, we undertake no obligation
to update or review any forward-looking statement because of new information, future events or other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We qualify all of our forward-looking
statements by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_005" TITLE="RISK FACTORS"></A>RISK FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>An investment in our
Common Stock involves a high degree of risk. Before deciding whether to invest in our Common Stock, you should consider carefully the
risks described below, as well as the risk factors contained in our most recent Annual Report on Form 10-K and Quarterly Reports on Form
10-Q, together with the other information contained in this prospectus supplement, in the accompanying base prospectus, and in the information
and documents incorporated by reference herein and therein. If any of these risks actually occurs, our business, financial condition,
results of operations and liquidity could be materially adversely impacted. This could cause the trading price of our Common Stock to
decline, resulting in a loss of all or part of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Risks Related to The Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>If you are issued shares of our Common Stock in this offering,
you may experience future dilution as a result of future issuance of equity securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We may be required to raise
additional capital in the future to fund the growth and operation of our business. To raise additional capital, we may offer additional
shares of our Common Stock, or other securities convertible into, or exercisable or exchangeable for, shares of our Common Stock, at prices
that may be lower than the deemed offering price of our Common Stock in this offering. In addition, investors purchasing our securities
in the future could have rights superior to those of our existing shareholders. Furthermore, if any of our outstanding options or warrants
are exercised at prices below the deemed offering price, or if we grant additional options or other awards under our equity incentive
plans, or if we issue additional convertible notes or warrants, you may experience further dilution of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B><I>We have never declared dividends on our
Common Stock and have no intention to declare dividends in the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We have never declared
or paid any dividends on our Common Stock and do not anticipate that we will pay any dividends to holders of our Common Stock in the foreseeable
future. We intend to use any excess cash for the development, operation and expansion of our business. The decision to pay cash dividends
on our Common Stock rests with our board of directors and will depend on a number of factors, including our financial condition, results
of operations and capital requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><A NAME="a_006" TITLE="DIVIDEND POLICY"></A>Dividend
Policy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have never declared or paid
any dividends on our Common Stock and do not anticipate that we will pay any dividends to holders of our Common Stock in the foreseeable
future. Instead, we currently plan to retain any earnings to finance the growth of our business. Any future determination relating to
dividend policy will be made at the discretion of our board of directors and will depend on our financial condition, results of operations,
and capital requirements, as well as other factors deemed relevant by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><A NAME="a_007" TITLE="USE OF PROCEEDS"></A>USE OF
PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are offering 100,000 shares
of our Common Stock pursuant to this prospectus and the Settlement Agreement. The shares are being issued in consideration of the amount
payable under the terms of the Settlement Agreement, and accordingly, no cash proceeds will be received by us from the issuance of the
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="text-transform: uppercase"><B>&nbsp;<BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="a_008" TITLE="DESCRIPTION OF CAPITAL STOCK"></A>DESCRIPTION OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">The material characteristics
of our Common Stock are described in the section entitled &ldquo;<I>Description of Capital Stock</I>&rdquo; in the accompanying base prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our Common Stock is Pacific Stock Transfer Company. Pacific Stock Transfer Company&rsquo;s address is 6725 Via Austi Pkwy, Suite 300,
Las Vegas, Nevada 89119 and telephone number is (800) 785-7782.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_009" TITLE="PLAN OF DISTRIBUTION"></A>PLAN </B></FONT><B>OF
DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are offering 100,000 shares
of our Common Stock pursuant to this prospectus and the Settlement Agreement. The shares are being issued in consideration of the amount
payable under the terms of the Settlement Agreement, and accordingly, no cash proceeds will be received by us from the issuance of the
shares. We currently anticipate that the shares will be delivered to Alexander on or about May 8, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><B>Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We will pay all of our expenses
in connection with the registration, offering, and issuance of the shares of our Common Stock pursuant to the Settlement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Nasdaq Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed on
Nasdaq under the symbol &ldquo;XPON.&rdquo; On May 6, 2024, the last reported sale price of our Common Stock on Nasdaq was $1.88 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Other Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We know of no existing arrangements
between Alexander and any of our other shareholders, brokers, dealers, underwriters or agents relating to the sale or distribution of
our Common Stock offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Alexander or its affiliates may
in the future engage in transactions with, and may perform, from time to time, investment banking and advisory services for us in the
ordinary course of their business and for which they would receive customary fees and expenses. In addition, in the ordinary course of
their business activities, Alexander and its affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for its own account and for the accounts
of its customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_010" TITLE="LEGAL MATTERS"></A>LEGAL MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The validity of the shares of
Common Stock offered under this prospectus will be passed upon by Stradling Yocca Carlson &amp; Rauth LLP, Newport Beach, California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_011" TITLE="EXPERTS"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial statements
of the Company as of December 31, 2023 and 2022, and for each of the two years in the period ended December 31, 2023, incorporated by
reference in this prospectus supplement, have been audited by M&amp;K CPAS, PLLC, an independent registered public accounting firm. Such
financial statements are incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting
and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_012" TITLE="WHERE YOU CAN FIND ADDITIONAL INFORMATION"></A>WHERE YOU
CAN FIND ADDITIONAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have filed with the SEC a registration
statement on Form S-3 under the Securities Act, and the rules and regulations promulgated thereunder, with respect to our Common Stock
offered under this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information
contained in the registration statement and the exhibits and schedules thereto. Certain contracts and other documents described in this
prospectus are filed as exhibits to the registration statement, or to documents incorporated by reference into the registration statement,
and you may review the full text of these contracts and documents by referring to these exhibits. For further information with respect
to us and our Common Stock offered under this prospectus, reference is made to the registration statement and its exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly and
current reports, proxy statements, and other information with the SEC. The SEC maintains a website that contains these reports, proxy
and information statements, and other information we file electronically with the SEC. Our filings are available free of charge at the
SEC&rsquo;s website at www.sec.gov. We also maintain a website at www.expion360.com, at which you may access these materials free of charge
as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible
through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual
reference only.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_013" TITLE="NCORPORATION OF CERTAIN INFORMATION BY REFERENCE"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; into this prospectus much of the information we file with the SEC, which means that we can disclose important information
to you by referring you to those publicly available documents. The information that we incorporate by reference into this prospectus is
considered to be part of this prospectus. These documents may include Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and
Current Reports on Form 8-K, as well as proxy statements and information statements. You should read the information incorporated by reference
because it is an important part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This prospectus incorporates by
reference the documents listed below, other than those documents or the portions of those documents deemed to be furnished and not filed
in accordance with SEC rules:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="width: 89%; padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on March 28, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">our Amendment No. 1 to our Annual Report on Form 10-K/A for the fiscal year ended December 31, 2023, as filed with the SEC on April 29, 2024;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding: 0.25pt; text-align: justify"><FONT STYLE="font-size: 10pt">the Description of Capital Stock contained in our Registration Statement on Form 8-A (File No. 001-41347), filed with the SEC on March 31, 2022, pursuant to Section 12 of the Exchange Act, as updated by Exhibit 4.4 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on March 28, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We also incorporate by reference
any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K, and exhibits filed on such form that
are related to such items, unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c),
14 or 15(d) of the Exchange Act after the date of this prospectus supplement but prior to the termination of this offering, and such future
filings will become a part of this prospectus from the respective dates that such documents are filed with the SEC. Any statement contained
herein, or in a document incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for
purposes hereof or of the related prospectus supplement to the extent that a statement contained herein or in any other subsequently filed
document which is also incorporated or deemed to be incorporated herein modifies or supersedes such statement. Any such statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">You may obtain copies of the documents
incorporated by reference in this prospectus from us free of charge by requesting them in writing or by telephone at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Greg Aydelott</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Expion360 Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2025 SW Deerhound Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Redmond, Oregon 97756</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(541) 797-6714</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Statements contained in this prospectus
as to the contents of any contract or other document are not necessarily complete, and in each instance investors are referred to the
copy of the contract or other document filed as an exhibit to the registration statement, each such statement being qualified in all respects
by such reference and the exhibits and schedules thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: center"><FONT STYLE="font-size: 10pt; line-height: 107%"><IMG SRC="image_002.jpg" ALT="Icon&#10;&#10;Description automatically generated" STYLE="height: 84px; width: 80px"></FONT></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><B>Expion360 Inc.</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>$50,000,000</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">From time to time,
we may offer and sell up to $50,000,000 in aggregate principal amount of our common stock, preferred stock, debt securities or warrants,
in each case in one or more issuances and at prices and on terms that we will determine at the time of the offering. We may also offer
common stock or preferred stock upon conversion of debt securities, common stock upon conversion of preferred stock, or common stock,
preferred stock or debt securities upon the exchange of warrants.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">This prospectus describes
the general manner in which any of these securities may be offered using this prospectus. We will specify in an accompanying prospectus
supplement the terms of the securities offered and other details regarding the offering thereof. The supplement may also add, update or
change information contained in this prospectus with respect to that offering.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">Our common stock is
listed on the Nasdaq Capital Market under the symbol &ldquo;XPON.&rdquo; On June 26, 2023, the last reported sales price of our common
stock was $4.76 per share.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">As of June 26, 2023,
the aggregate market value of our outstanding common stock held by non-affiliates, or public float, was approximately $24,867,078 million,
based on 6,910,717 shares of outstanding common stock, of which approximately 1,686,541 shares were held by affiliates, and a price of
$4.76 per share, which was the price at which our common stock was last sold on the Nasdaq Capital Market on such date. We have not offered
any securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12-calendar-month period that ends on and includes the
date of this prospectus. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities registered on this registration
statement in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as
our public float remains below $75 million (the &ldquo;Baby Shelf Limitation&rdquo;).</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">We are an &ldquo;emerging
growth company&rdquo; as defined under U.S. federal securities laws and, as such, have elected to comply with reduced public company reporting
requirements. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in">The securities covered
by this prospectus may be sold directly by us to investors, through agents designated by us from time to time or through underwriters
or dealers at prices and on terms to be determined at the time of offering. We will include in an applicable prospectus supplement the
names of any underwriters or agents and any applicable commissions or discounts. Additional information on the methods of sale appears
under &ldquo;<I>Plan of Distribution</I>&rdquo; in this prospectus. We will also describe in an applicable prospectus supplement the way(s)
in which we expect to use the net proceeds we receive from any sale.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><B>Investing in our
securities involves risks. See the section entitled &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 7 of this prospectus to read about
factors you should consider before buying our securities. </B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><B>This prospectus
may not be used to offer or sell any securities unless accompanied by a prospectus supplement.</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: center"><B>The date of this prospectus is July 10,
2023</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: center"><B></B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; padding-bottom: 1pt; width: 92%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">INCORPORATION BY REFERENCE </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">PROSPECTUS SUMMARY </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">RISK FACTORS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">USE OF PROCEEDS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">GENERAL DESCRIPTION OF SECURITIES </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">LEGAL MATTERS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">EXPERTS </FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><B>You should rely
only on the information contained, or incorporated by reference, in this prospectus and in an applicable prospectus supplement to this
prospectus. We have not authorized any other person to provide you with different or additional information. If anyone provides you with
different, additional or inconsistent information, you should not rely on it. We do not take responsibility for, and can provide no assurance
as to the reliability of, any other information that others may give you. We are not making an offer to sell these securities or soliciting
any offer to buy these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information
appearing in this prospectus, any applicable prospectus supplement or any free writing prospectus we authorize to be delivered to you
is accurate only as of the date of that document or any other date set forth in that document. Additionally, any information we have incorporated
by reference in this prospectus or in any applicable prospectus supplement is accurate only as of the date of the document incorporated
by reference or other date set forth in that document, regardless of the time of delivery of this prospectus, any applicable prospectus
supplement or any sale of securities. Our business, financial condition, results of operations, cash flow and prospects may have changed
since that date.</B></P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 9pt; text-align: justify"></P>
<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_014" TITLE="ABOUT THIS PROSPECTUS"></A>ABOUT THIS
PROSPECTUS</B></FONT></P>

<P STYLE="text-align: justify; margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This prospectus
is part of a registration statement on Form S-3 that we have filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
using a &#8220;shelf&#8221; registration process.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under this
process, we may sell the securities described in this prospectus in one or more offerings for an aggregate offering amount of up to $50,000,000,
subject to the Baby Shelf Limitation. This prospectus describes the general manner in which we may offer the securities described in
this prospectus. Each time we sell securities pursuant to this registration statement, we will provide a prospectus supplement that will
contain specific information about the offering and the securities offered, and may also add, update or change information contained
in this prospectus. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information
relating to these offerings. If there is any inconsistency between information in this prospectus and any accompanying prospectus supplement
or free writing prospectus, you should rely on the information in the most recent applicable prospectus supplement or free writing prospectus
and documents incorporated by reference herein and therein. This prospectus may not be used to offer to sell, solicit an offer to buy
or consummate a sale of our securities unless it is accompanied by a prospectus supplement.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This prospectus,
together with any accompanying prospectus supplement and any additional information incorporated by reference herein and therein, contains
important information you should know before investing in our securities, including important information about us and the securities
being offered. You should carefully read both documents, as well as the additional information contained in the documents described under
&#8220;<I>Where You Can Find More Information</I>&#8221; and &#8220;<I>Incorporation By Reference</I>&#8221; in both this prospectus
and any applicable prospectus supplement, and in particular the annual, quarterly and current reports and other documents we file with
the SEC. Neither this prospectus nor any accompanying prospectus supplement is an offer to sell these securities or is soliciting an
offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This prospectus
contains or incorporates by reference summaries of certain provisions contained in some of the documents described herein, but reference
is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents.
Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to
the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below in the
section of this prospectus entitled &#8220;<I>Incorporation By Reference.</I>&#8221;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELECTED
DEFINITIONS </B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise
stated in this prospectus or the context otherwise requires, reference to:</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>Articles
of Incorporation</I>&#8221; means the articles of incorporation of Expion360.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>Bylaws</I>&#8221;
means the bylaws of Expion360.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>common
stock</I>&#8221; means the shares of common stock, par value $0.001 per share, of Expion360.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>Exchange
Act</I>&#8221; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>Expion360</I>&#8221;,
the &#8220;<I>Company,</I>&#8221; &#8220;<I>we</I>,&#8221; &#8220;<I>us</I>,&#8221; and &#8220;<I>our</I>&#8221; means Expion360 Inc.,
a Nevada corporation.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>SEC</I>&#8221;
means the Securities and Exchange Commission.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<I>Securities
Act</I>&#8221; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="margin: 0 0 12pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><A NAME="a_015" TITLE="CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS"></A>CAUTIONARY
NOTE&nbsp;REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, together with any accompanying prospectus supplement, and the documents incorporated by reference herein or therein may include
&#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act.
All statements in this prospectus, together with any accompanying prospectus supplement, and the documents incorporated by reference
herein or therein, other than statements of historical fact, are &#8220;forward-looking statements&#8221; for purposes of these provisions,
including, without limitation, any projections regarding the markets where we operate, any statements of the plans and objectives of
our management for future operations, any statements concerning proposed new products or services, any statements regarding expected
capital expenditures, any statements regarding future economic conditions or performance, and any statements of assumptions underlying
any of the foregoing. All forward-looking statements included in this prospectus and the documents incorporated by reference herein are
made as of the date hereof or thereof, as applicable, and are based on information available to us as of such dates. We assume no obligation
to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as
&#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;should,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221;
&#8220;seeks,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;forecasts,&#8221; &#8220;continue,&#8221;
or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. Although we believe
that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such
expectations or any of the forward-looking statements will prove to be correct. Actual results will likely differ, and could differ materially,
from those projected or assumed in the forward-looking statements. Prospective investors are cautioned not to unduly rely on any such
forward-looking statements.</FONT></P>

<P STYLE="margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations,
and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy,
and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks,
and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial
condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these
forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those
indicated in the forward-looking statements include, among others, the following:</FONT></P>

<P STYLE="margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0 0 6pt"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate in an extremely
    competitive industry and are subject to pricing pressures.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have a history of losses
    and our audited financial statements include a statement that there is a substantial doubt about our ability to continue as a going
    concern. As our costs increase, we may not be able to generate sufficient revenue to achieve and sustain profitability.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our business and future
    growth depends on the needs and success of our customers, and we have substantial customer concentration.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to successfully
    manage our growth.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may be negatively impacted
    by public health epidemics or outbreaks, including the novel coronavirus (&#8220;COVID-19&#8221;) as well as uncertainty in global
    economic conditions.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may fail to expand our
    sales and distribution channels and our ability to expend into international markets is uncertain.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nearly all of our raw materials
    enter the United States through a limited number of ports, and we rely on third parties to store and ship some of our inventory;
    labor unrest at these ports or other product delivery difficulties could interfere with our distribution plans and reduce our revenue.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government reviews, inquiries,
    investigations, and actions could harm our business or reputation.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are dependent on third-party
    manufacturers and suppliers, including suppliers located outside the United States, and our operating results could be adversely
    affected by changes in the cost and availability of raw materials as well as increases in costs, disruption of supply, or shortage
    of any of our battery components, such as electronic and mechanical parts, or raw materials used in the production of such parts.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We rely on two warehouse
    facilities and if any of our facilities becomes inoperable for any reason or if our expansion plans fail, our ability to produce
    our products could be negatively impacted.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lithium-ion battery cells
    have been observed to catch fire or release smoke and flame, which may have a negative impact on our reputation and business.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We could face potential
    product liability claims relating to our products, which could result in significant costs and liabilities, which would reduce our
    profitability.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operations expose us
    to litigation, tax, environmental, and other legal compliance risks.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our failure to introduce
    new products and product enhancements and broad market acceptance of new technologies introduced by our competitors could adversely
    affect our business.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may not be able to adequately
    protect our proprietary intellectual property and technology and we may need to defend ourselves against intellectual property infringement
    claims.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality problems with our
    products could harm our reputation and erode our competitive position.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to raise capital
    in the future may be limited and our stockholders may be diluted by future securities offerings.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We depend on our senior
    management team and other key employees, and significant attrition within our management team or unsuccessful succession planning
    could adversely affect our business.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are an &#8220;emerging
    growth company&#8221; and elect to comply with certain reduced reporting requirements applicable to emerging growth companies, which
    could make our securities less attractive to investors.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such other factors as discussed
    under &#8220;Risk Factors&#8221; herein and in the documents incorporated by reference herein, including our latest Annual Report
    on Form 10-K.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary
statements. Our actual results will likely differ, and may differ materially, from anticipated results. Financial estimates are subject
to change and are not intended to be relied upon as predictions of future operating results, and we assume no obligation to update or
disclose revisions to those estimates. If we do update or correct one or more forward-looking statements, investors and others should
not conclude that we will make additional updates or corrections.</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_016" TITLE="WHERE YOU CAN FIND MORE INFORMATION"></A>WHERE YOU
CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have filed
with the SEC a registration statement on Form S-3, including exhibits, under the Securities Act with respect to the securities offered
by this prospectus and any applicable prospectus supplement. This prospectus and the applicable prospectus supplement, which constitutes
part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further
information with respect to Expion360 and the securities offered by this prospectus and any applicable prospectus supplement, we refer
you to the registration statement and its exhibits. Statements contained in this prospectus and any applicable prospectus supplement
as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you
to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified
in all respects by this reference. You can read our SEC filings, including the registration statement, at the SEC&#8217;s website at
www.sec.gov.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject
to the information reporting requirements of the Exchange Act, and we are required to file reports, proxy statements and other information
with the SEC. These reports, proxy statements and other information will be available for review at the SEC&#8217;s website referred
to above. We also maintain a website at www.expion360.com, at which you may access these materials free of charge as soon as reasonably
practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website
is not a part of this prospectus or any prospectus supplement, and the inclusion of our website address in this prospectus or any prospectus
supplement is an inactive textual reference only.</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_017" TITLE="INCORPORATION BY REFERENCE"></A>INCORPORATION
BY REFERENCE</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC&#8217;s
rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus and any applicable prospectus supplement, which
means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information
incorporated by reference is deemed to be part of this prospectus and any applicable prospectus supplement, and subsequent information
that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or any
applicable prospectus supplement or a previously filed document incorporated by reference will be deemed to be modified or superseded
for purposes of this prospectus or any applicable prospectus supplement to the extent that a statement contained in this prospectus or
any applicable prospectus supplement or a subsequently filed document incorporated by reference modifies or replaces that statement.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This prospectus
and any applicable prospectus supplement incorporate by reference the documents set forth below that have previously been filed with
the SEC:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Annual Report on <FONT STYLE="color: blue"><A HREF="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/0001903596-23-000244-index.htm">Form 10-K</A></FONT> for the year ended December 31,
                                            2022, filed with the SEC on March 30, 2023; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Quarterly Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000392/0001903596-23-000392-index.htm">Form 10-Q</A> for the period ended March 31, 2023, filed with the SEC on
                                            May 11, 2023; &nbsp;&nbsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Current Report on <A HREF="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000096/0001903596-23-000096-index.htm">Form 8-K</A> filed with the SEC on February 1, 2023; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            description of the common stock contained in our registration statement on <FONT STYLE="color: blue"><A HREF="https://www.sec.gov/Archives/edgar/data/1894954/000190359622000149/0001903596-22-000149-index.htm">Form 8-A</A></FONT> (File No. 001-41347), filed with the SEC on March 31, 2022, pursuant to Section
                                            12 of the Exchange Act, as updated by <FONT STYLE="color: blue"><A HREF="https://www.sec.gov/Archives/edgar/data/1894954/000190359623000244/ex4_4.htm">Exhibit 4.4</A></FONT> to our
                                            Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on March
                                            30, 2023.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All reports
and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of
this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to
the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also
be incorporated by reference into this prospectus or any applicable prospectus supplement and deemed to be part of this prospectus or
any applicable prospectus supplement from the date of the filing of such reports and documents. Under no circumstances shall any information
furnished under Item 2.02, 7.01 or 9.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides
to the contrary.</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_018" TITLE="PROSPECTUS SUMMARY"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The following
summary highlights information contained in greater details elsewhere in this prospectus or incorporated by reference into this prospectus.
This summary is not complete and does not contain all of the information you should consider in making your investment decision. You
should read the entire prospectus, any applicable prospectus supplement and the documents we have incorporated by reference in this prospectus
carefully before making an investment in our securities. You should carefully consider, among other things, our financial statements
and related notes and the information set forth in the section entitled &#8220;Risk Factors&#8221; and other information incorporated
by reference into this prospectus from our filings with the SEC. See also the sections entitled &#8220;Where You Can Find More Information&#8221;
and &#8220;Incorporation By Reference.&#8221; </I></FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
Inc. (the &#8220;Company,&#8221; &#8220;Expion360&#8221;, &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) focuses on the design,
assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles
(&#8220;RVs&#8221;) and marine applications with plans to expand into home energy storage products and industrial applications. We design,
assemble, and distribute high-powered, lithium battery solutions using ground-breaking concepts with a creative sales and marketing approach.
We believe that our product offerings include some of the most dense and minimal-footprint batteries in the RV &amp; Marine industry.
We are developing the e360 Home Energy Storage: a system that we expect to significantly change the industry in barrier price, flexibility,
and integration. We are deploying multiple IP strategies with cutting-edge research and unique products to sustain and scale the business.
We currently have customers consisting of dealers, wholesalers, private label customers and original equipment manufacturers who are
driving revenue and brand awareness nationally.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters are based in Redmond, Oregon, with assembly in the United States and suppliers based in Asia and Europe. We are
currently in the process of building out manufacturing capacity at our corporate headquarters. Our long-term target is to onshore the
manufacturing of most of our components and assemblies, including cell manufacturing, to the United States.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
main target markets are currently the RV &amp; Marine industry. We believe that we are well positioned to capitalize on the rapid market
conversion from lead-acid to lithium batteries as the primary method of power sourcing in these industries. Additional focus markets
include home energy storage, where we aim to provide a cost-effective, low barrier of entry, and a do-it-yourself (&#8220;DIY&#8221;)
flexible system for those looking to power their homes via solar energy, wind, or grid back-up. Along with RV/Marine and home energy
storage markets, we aim to provide additional capacities to the ever-expanding electric forklift and industrial material handling markets.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360&#8217;s
e360 product line, which is manufactured for the RV/Marine industry, was launched in December 2020. The e360 product line, through its
rapid sales growth, has shown to be a preferred conversion solution for lead-acid batteries. We believe that our e360 Home Energy Storage
system has strong revenue potential with recurring income opportunities for us and our associated sales partners.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our products
provide numerous advantages for various industries that are looking to migrate to lithium-based energy storage. They incorporate detailed-oriented
design and engineering and strong case materials and internal and structural layouts, and are backed by responsive customer service.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate Information</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360 Inc.
was initially organized as a limited liability company under the name Yozamp Products Company, LLC in the State of Oregon on June 16,
2016, and converted to a Nevada corporation under its current name pursuant to articles of conversion dated as of November 16, 2021.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
website is https://expion360.com/ and on the Investor Relations section of our website, we post or will post, as applicable, the following
filings as soon as reasonably practicable after they are electronically filed with or furnished
to the Securities and Exchange Commission (&#8220;SEC&#8221;): our Annual Report on Form 10-K (the &#8220;Annual Report&#8221;), our
Proxy Statement on Schedule 14A, our Quarterly Reports on Form 10-Q, our Current Reports on Form 8-K and any amendments to those reports
filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended.</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 12pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the information on our Investor Relations web page is available to be viewed free of charge. Information contained on our website
is not part of this prospectus or our other filings with the SEC. We assume no obligation to update or revise any forward-looking statements
in this prospectus whether as a result of new information, future events or otherwise, unless we are required to do so by law.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC also maintains a website (www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers
that file electronically with the SEC.</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_019" TITLE="RISK FACTORS"></A>RISK FACTORS</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
in the securities offered pursuant to this prospectus and any applicable prospectus supplement involves risks. You should carefully consider
the risk factors incorporated by reference to our most recent Annual Report on Form 10-K, and any subsequent Quarterly Reports on Form
10-Q or Current Reports on Form 8-K, and all other information contained or incorporated by reference into this prospectus, as updated
by our subsequent filings under the Exchange Act, and the risk factors and other information contained in or incorporated by reference
into any applicable prospectus supplement before acquiring any of such securities. The risks and uncertainties we have described are
not the only ones facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also affect our business operations. The occurrence of any of these risks might cause you to lose all or part of your investment
in the offered securities. The discussion of risks includes or refers to forward-looking statements. You should read the explanation
of the qualifications and limitations on such forward-looking statements contained or incorporated by reference into this prospectus
and in any applicable prospectus supplement.</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_020" TITLE="USE OF PROCEEDS"></A>USE OF PROCEEDS</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise
described in any applicable prospectus supplement, we intend to use the net proceeds from the sale of any securities described in this
prospectus for general corporate purposes.</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_021" TITLE="GENERAL DESCRIPTION OF SECURITIES"></A>GENERAL DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may offer
shares of common stock or preferred stock, various series of senior or subordinated debt securities or warrants to purchase any of the
foregoing, in each case from time to time under this prospectus, together with any applicable prospectus supplement, at prices and on
terms to be determined by market conditions at the time of offering. This prospectus provides you with a general description of the securities
we may offer. At the time we offer a particular type or series of securities, we will provide an applicable prospectus supplement describing
the specific amounts, prices and other important terms of the securities, including, to the extent applicable:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designation
                                            or classification; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">aggregate
                                            principal amount or aggregate offering price; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
                                            or other rights; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rates
                                            and times of payment of interest, dividends or other payments; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liquidation
                                            preference; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">original
                                            issue discount; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maturity;
                                            </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ranking;
                                            </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictive
                                            covenants; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">redemption,
                                            conversion, exercise, exchange, settlement or sinking fund terms, including prices or rates,
                                            and any provisions for changes to or adjustments in such prices or rates and in the securities
                                            or other property receivable upon conversion, exercise, exchange or settlement; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            securities exchange or market listing arrangements; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">important
                                            U.S. federal income tax considerations.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This prospectus
may not be used to offer or sell securities unless accompanied by an applicable prospectus supplement. The applicable prospectus supplement
may add, update or change information contained in this prospectus or in documents incorporated by reference in this prospectus. You
should read the applicable prospectus supplement related to any securities being offered.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may sell
the securities to or through underwriters, dealers or agents, directly to purchasers or through a combination of any of these methods
of sale or as otherwise set forth under &#8220;<I>Plan of Distribution</I>&#8221;. We and our underwriters, dealers or agents reserve
the right to accept or reject all or part of any proposed purchase of securities. If we do offer securities through underwriters or agents,
we will include in the applicable prospectus supplement (i) the names of the underwriters or agents and applicable fees, discounts and
commissions to be paid to them; (ii) details regarding over-allotment options, if any; and (iii) net proceeds to us.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
descriptions are not complete and may not contain all the information you should consider before investing in any securities we may offer
hereunder; they are summarized from, and qualified by reference to, our articles of incorporation, bylaws and the other documents referred
to in herein, all of which are or will be publicly filed with the SEC, as applicable. See &#8220;<I>Where You Can Find More Information</I>.&#8221;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_022" TITLE="DESCRIPTION OF CAPITAL STOCK"></A>DESCRIPTION
OF CAPITAL STOCK</B>&nbsp;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expion360
has one class of securities registered under Section 12 of the Securities Exchange Act: the Company&#8217;s common stock, par value $0.001
per share (the &#8220;common stock&#8221;).</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description of our capital stock is a summary of the rights of our capital stock and summarizes certain provisions of our certificate
of incorporation and our bylaws. This summary does not purport to be complete and is qualified in its entirety by the provisions of our
certificate of incorporation and bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus
forms a part, as well as to the applicable provisions of Nevada law.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 200,000,000 shares of common stock, par value $0.001 per share and 20,000,000 shares of preferred
stock, par value $0.001 per share.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The
holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any
dividends declared by the board of directors out of funds legally available for that purpose, subject to any preferential dividend rights
of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption
or sinking fund provisions. We currently do not have any shares of, or securities convertible into, preferred stock outstanding.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets
remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>$2.90
Warrants</I></B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 9, 2021, the Company issued warrants to purchase 151,000 of shares of the Company&#8217;s common stock with an exercise price
of $2.90 per share (the &#8220;$2.90 Warrants&#8221;). The $2.90 Warrants are exercisable for a period of 3 years from date of grant.
If holders of the $2.90 Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their
$2.90 Warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the difference between the &#8220;fair
market value&#8221; (defined below) multiplied by the number of shares underlying such holder&#8217;s $2.90 Warrants and the exercise
price multiplied by the number of shares underlying such holder&#8217;s $2.90 Warrants by (y) the fair market value. The &#8220;fair
market value&#8221; shall mean the prior five-day average closing price of the common stock on the date on which the holder elects to
exercise their $2.90 Warrants. The $2.90 Warrants have certain adjustment rights upon certain events.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>$3.32
Warrants</I></B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 22, 2021, the Company issued warrants to purchase 559,431 shares of the Company&#8217;s common stock at an exercise price of
$3.32 per share (the &#8220;$3.32 Warrants&#8221;). The $3.32 Warrants are exercisable for a period of 10 years from date of grant. If
holders of the $3.32 Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering their $3.32
Warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the difference between the &#8220;fair
market value&#8221; (defined below) multiplied by the number of shares underlying such holder&#8217;s $3.32 Warrants and the exercise
price multiplied by the number of shares underlying such holder&#8217;s $3.32 Warrants by (y) the fair market value. The &#8220;fair
market value&#8221; shall mean the volume weighted average of the closing sales price of the common stock averaged over 20 consecutive
trading days ending on the trading day prior to the date on which &#8220;fair market value&#8221; is determined. The $3.32 Warrants have
certain adjustment rights upon certain events. The Company is required to cause a registration statement registering the resale of the
shares of our common stock issuable upon exercise of the $3.32 Warrants to become effective in connection with its initial public offering.
As of the date of this prospectus, the Company has an effective registration statement which satisfies this requirement.</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Underwriter
Warrants</I></B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the closing of the initial public offering, the Company issued warrants to purchase an aggregate of 128,700 shares of its common
stock to Alexander Capital LP and Paulson Investment Company LLC (as apportioned in accordance with agreements amongst them), or their
designees, at an exercise price of $9.10 per share (the &#8220;Underwriter Warrants&#8221;). The Underwriter Warrants are initially exercisable
on September 27, 2022 and expire on March 31, 2027.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
there is not an effective registration statement registering the resale of the shares of common stock issuable upon exercise of the Underwriter
Warrants, holders of the Underwriter Warrants may elect to exercise them on a cashless basis and pay the exercise price by surrendering
their Underwriter Warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the
number of shares of common stock underlying the Underwriter Warrants, multiplied by the difference between (i) the daily volume weighted
average price of the common stock on the trading day immediately preceding the date of the exercise notice or on the date of the exercise
notice (if delivered after regular trading hours) and (ii) the exercise price of the Underwriter Warrants and by (y) the daily volume
weighted average price of the common stock on the trading day immediately preceding the date of the exercise notice or on the date of
the exercise notice (if delivered after regular trading hours). If the Company does not deliver common stock to a holder upon such holder&#8217;s
exercise of their Underwriter Warrants in compliance with the timing set out in the Underwriter Warrants, the Company will have to pay
cash to such holder in accordance with the terms of the Underwriter Warrants. The Underwriter Warrants include anti-dilution provisions
(for stock dividends, splits and recapitalizations and similar transactions), which results in the adjustment of the exercise price and
entitles holders of the Underwriter Warrants to participate in subsequent rights offerings or distributions to holders of the Company&#8217;s
common stock, as applicable. The Underwriter Warrants also have certain adjustment rights upon certain events. Further, the Underwriter
Warrants provide for a one-time demand registration right, exercisable until March 31, 2027 and unlimited piggyback rights, exercisable
until September 27, 2024.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Options</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our initial public offering, we issued options to purchase 30,000 shares of common stock granted to one individual which had an exercise
price of $3.32.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects of Provisions of Our Charter Documents</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of Nevada law and our Bylaws may have the effect of delaying, deferring or preventing another party from acquiring control
of the company. These provisions may discourage and prevent coercive takeover practices and inadequate takeover bids.</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nevada
Law</I></B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada
law contains a provision governing &#8220;acquisition of controlling interest.&#8221; This law provides generally that any person or
entity that acquires 20% or more of the outstanding voting shares of a publicly-held Nevada corporation in the secondary public or private
market may be denied voting rights with respect to the acquired shares, unless a majority of the disinterested stockholders of the corporation
elects to restore such voting rights in whole or in part. The control share acquisition act provides that a person or entity acquires
&#8220;control shares&#8221; whenever it acquires shares that, but for the operation of the control share acquisition act, would bring
its voting power within any of the following three ranges: 20 to 33-1/3%; 33-1/3 to 50%; or more than 50%.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles of Incorporation include a mandatory forum provision that, to the fullest extent permitted by law, the Nevada Eighth Judicial
District of Clark County Nevada shall be the sole and exclusive forum for (a) any derivative action or proceeding brought in the name
or right of the Company or on its behalf, (b) any action asserting a claim for breach of any fiduciary duty owed by any director, officer,
employee or agent of the Company to the Company or the Company's stockholders, (c) any action arising or asserting a claim arising pursuant
to any provision of NRS Chapters 78 or 92Aor any provision of the Articles of Incorporation or Bylaws, (d) any action to interpret, apply,
enforce or determine the validity of the Articles of Incorporation or Bylaws or (e) any action asserting a claim governed by the internal
affairs doctrine. This exclusive forum provision would not apply to suits brought to enforce any liability or duty created by the Securities
Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims
may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to
enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Furthermore, Section 22 of the Securities
Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the
Securities Act or rules and regulations thereunder and would preempt the choice of forum provisions in our Articles of Incorporation
with respect to such matters.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;control share acquisition&#8221; is generally defined as the direct or indirect acquisition of either ownership or voting power
associated with issued and outstanding control shares. The stockholders or Board of Directors of a corporation may elect to exempt the
stock of the corporation from the provisions of the control share acquisition act through adoption of a provision to that effect in the
articles of incorporation or bylaws of the corporation. Our Articles of Incorporation and Bylaws do not exempt our common stock from
the control share acquisition act.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
control share acquisition act is applicable only to shares of &#8220;Issuing Corporations&#8221; as defined by the Nevada law. An Issuing
Corporation is a Nevada corporation which (i) has 200 or more stockholders, with at least 100 of such stockholders being both stockholders
of record and residents of Nevada, and (ii) does business in Nevada directly or through an affiliated corporation.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, we do not believe we have 100 stockholders of record resident of Nevada and we do not conduct business in Nevada directly.
Therefore, the provisions of the control share acquisition act are believed not to apply to acquisitions of our shares and will not until
such time as these requirements have been met. At such time as they may apply, the provisions of the control share acquisition act may
discourage companies or persons interested in acquiring a significant interest in or control of us, regardless of whether such acquisition
may be in the interest of our stockholders.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nevada &#8220;Combination with Interested Stockholders Statute&#8221; may also have an effect of delaying or making it more difficult
to effect a change in control of us. This statute prevents an &#8220;interested stockholder&#8221; and a resident domestic Nevada corporation
from entering into a &#8220;combination,&#8221; unless certain conditions are met. The statute defines &#8220;combination&#8221; to include
any merger or consolidation with an &#8220;interested stockholder,&#8221; or any sale, lease, exchange, mortgage, pledge, transfer or
other disposition, in one transaction or a series of transactions with an &#8220;interested stockholder&#8221; having (i) an aggregate
market value equal to 5% or more of the aggregate market value of the assets of the corporation, (ii) an aggregate market value equal
to 5% or more of the aggregate market value of all outstanding shares of the corporation, or (iii) representing 10% or more of the earning
power or net income of the corporation.</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
&#8220;interested stockholder&#8221; means the beneficial owner of 10% or more of the voting shares of a resident domestic corporation,
or an affiliate or associate thereof. A corporation affected by the statute may not engage in a &#8220;combination&#8221; within three
years after the interested stockholder acquires its shares unless the combination or purchase is approved by the Board of Directors before
the interested stockholder acquired such shares. If approval is not obtained, then after the expiration of the three-year period, the
business combination may be consummated with the approval of the Board of Directors or a majority of the voting power held by disinterested
stockholders, or if the consideration to be paid by the interested stockholder is at least equal to the highest of (i) the highest price
per share paid by the interested stockholder within the three years immediately preceding the date of the announcement of the combination
or in the transaction in which he became an interested stockholder, whichever is higher, (ii) the market value per common share on the
date of announcement of the combination or the date the interested stockholder acquired the shares, whichever is higher, or (iii) if
higher for the holders of preferred stock, the highest liquidation value of the preferred stock.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Articles
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Articles of Incorporation are silent as to cumulative voting rights in the election of our directors. Nevada law requires the existence
of cumulative voting rights to be provided for by a corporation&#8217;s Articles of Incorporation. In the event that a few stockholders
end up owning a significant portion of our issued and outstanding common stock, the lack of cumulative voting would make it more difficult
for other stockholders to replace our Board of Directors or for a third party to obtain control of us by replacing our Board of Directors.
Our Articles of Incorporation and Bylaws do not contain any explicit provisions that would have an effect of delaying, deferring or preventing
a change in control of us.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common shares is Pacific Stock Transfer Company. Pacific Stock Transfer Company&#8217;s address
and phone number is: 6725 Via Austi Pkwy, Suite 300, Las Vegas, Nevada 89119; telephone number (800) 785-7782.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock has been traded on The Nasdaq Capital Market under the symbol &#8220;XPON&#8221; since April 1, 2022.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_023" TITLE="DESCRIPTION OF DEBT SECURITIES"></A>DESCRIPTION
OF DEBT SECURITIES</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may issue
debt securities from time to time, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible
debt. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we
will describe the particular terms of any debt securities that we may offer in more detail in the applicable prospectus supplement. The
terms of any debt securities offered under a prospectus supplement may differ from the terms described below. Unless the context requires
otherwise, whenever we refer to the indenture, we also are referring to any supplemental indentures that specify the terms of a particular
series of debt securities.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will issue
the debt securities under the indenture that we will enter into with the trustee named in the indenture. The indenture will be qualified
under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. We have filed the form of indenture as an exhibit to the
registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing the terms
of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a part or will
be incorporated by reference from reports that we file with the SEC.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
summary of material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to,
all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read the applicable prospectus
supplements and any related free writing prospectuses related to the debt securities that we may offer under this prospectus, as well
as the complete indenture that contains the terms of the debt securities.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indenture
does not limit the amount of debt securities that we may issue. It provides that we may issue debt securities up to the principal amount
that we may authorize and that the debt securities may be in any currency or currency unit that we may designate. Except for the limitations
on consolidation, merger and sale of all or substantially all of our assets contained in the indenture, the terms of the indenture do
not contain any covenants or other provisions designed to give holders of any debt securities protection against changes in our operations,
financial condition or transactions involving us.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will describe
in the applicable prospectus supplement the terms of the series of debt securities being offered, including:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            title of the series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            limit upon the aggregate principal amount that may be issued;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            maturity date or dates;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            form of the debt securities of the series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            applicability of any guarantees;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            or not the debt securities will be secured or unsecured, and the terms of any secured debt;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the debt securities rank as senior debt, senior subordinated debt, subordinated debt or any
                                            combination thereof, and the terms of any subordination;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the price (expressed as a percentage of the aggregate principal amount thereof) at which
                                            such debt securities will be issued is a price other than the principal amount thereof, the
                                            portion of the principal amount thereof payable upon declaration of acceleration of the maturity
                                            thereof, or if applicable, the portion of the principal amount of such debt securities that
                                            is convertible into another security or the method by which any such portion shall be determined;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            interest rate or rates, which may be fixed or variable, or the method for determining the
                                            rate and the date interest will begin to accrue, the dates interest will be payable and the
                                            regular record dates for interest payment dates or the method for determining such dates;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            right, if any, to defer payment of interest and the maximum length of any such deferral period;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the date or dates after which, or the period or periods during which, and the
                                            price or prices at which, we may, at our option, redeem the series of debt securities pursuant
                                            to any optional or provisional redemption provisions and the terms of those redemption provisions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date or dates, if any, on which, and the price or prices at which we are obligated, pursuant
                                            to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at
                                            the holder&#8217;s option to purchase, the series of debt securities and the currency or
                                            currency unit in which the debt securities are payable;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            denominations in which we will issue the series of debt securities, if other than denominations
                                            of $1,000 and any integral multiple thereof;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            and all terms, if applicable, relating to any auction or remarketing of the debt securities
                                            of that series and any security for our obligations with respect to such debt securities
                                            and any other terms which may be advisable in connection with the marketing of debt securities
                                            of that series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            the debt securities of the series shall be issued in whole or in part in the form of a global
                                            security or securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            terms and conditions, if any, upon which such global security or securities may be exchanged
                                            in whole or in part for other individual securities; and the depositary for such global security
                                            or securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the provisions relating to conversion or exchange of any debt securities of the
                                            series and the terms and conditions upon which such debt securities will be so convertible
                                            or exchangeable, including the conversion or exchange price, as applicable, or how it will
                                            be calculated and may be adjusted, any mandatory or optional (at our option or the holders&#8217;
                                            option) conversion or exchange features, the applicable conversion or exchange period and
                                            the manner of settlement for any conversion or exchange;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            other than the full principal amount thereof, the portion of the principal amount of debt
                                            securities of the series which shall be payable upon declaration of acceleration of the maturity
                                            thereof;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or changes in the covenants applicable to the particular debt securities being issued,
                                            including, among others, the consolidation, merger or sale covenant;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or changes in the events of default with respect to the securities and any change in the
                                            right of the trustee or the holders to declare the principal, premium, if any, and interest,
                                            if any, with respect to such securities to be due and payable;</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or changes in or deletions of the provisions relating to covenant defeasance and legal
                                            defeasance;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or changes in the provisions relating to satisfaction and discharge of the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
                                            to or changes in the provisions relating to the modification of the indenture both with and
                                            without the consent of holders of debt securities issued under the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            currency of payment of debt securities if other than U.S. dollars and the manner of determining
                                            the equivalent amount in U.S. dollars;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
                                            interest will be payable in cash or additional debt securities at our or the holders&#8217;
                                            option and the terms and conditions upon which the election may be made;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            terms and conditions, if any, upon which we will pay amounts in addition to the stated interest,
                                            premium, if any and principal amounts of the debt securities of the series to any holder
                                            that is not a &#8220;United States person&#8221; for federal tax purposes;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            restrictions on transfer, sale or assignment of the debt securities of the series; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other specific terms, preferences, rights or limitations of, or restrictions on, the debt
                                            securities, any other additions or changes in the provisions of the indenture, and any terms
                                            that may be required by us or advisable under applicable laws or regulations.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may issue
the debt securities issued under the indenture as &#8220;discount securities,&#8221; which means they may be sold at a discount below
their stated principal amount. These debt securities, as well as other debt securities that are not issued at a discount, may be issued
with &#8220;original issue discount,&#8221; or OID, for U.S. federal income tax purposes because of interest payment and other characteristics
or terms of the debt securities. Material U.S. federal income tax considerations applicable to debt securities issued with OID will be
described in more detail in any applicable prospectus supplement.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion or Exchange Rights</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will set
forth in the applicable prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable
for our common stock or our other securities. We will include provisions as to settlement upon conversion or exchange and whether conversion
or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares
of our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidation, Merger or Sale</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless we provide
otherwise in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant
that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety or substantially
as an entirety. However, any successor to or acquirer of such assets (other than a subsidiary of ours) must assume all of our obligations
under the indenture or the debt securities, as appropriate.</FONT></P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Events of Default Under the Indenture</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless we provide
otherwise in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under
the indenture with respect to any series of debt securities that we may issue:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            we fail to pay any installment of interest on any series of debt securities, as and when
                                            the same shall become due and payable, and such default continues for a period of 90 days;
                                            provided, however, that a valid extension of an interest payment period by us in accordance
                                            with the terms of any indenture supplemental thereto shall not constitute a default in the
                                            payment of interest for this purpose;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            we fail to pay the principal of, or premium, if any, on any series of debt securities as
                                            and when the same shall become due and payable whether at maturity, upon redemption, by declaration
                                            or otherwise, or in any payment required by any sinking or analogous fund established with
                                            respect to such series; provided, however, that a valid extension of the maturity of such
                                            debt securities in accordance with the terms of any indenture supplemental thereto shall
                                            not constitute a default in the payment of principal or premium, if any;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            we fail to observe or perform any other covenant or agreement contained in the debt securities
                                            or the indenture, other than a covenant specifically relating to another series of debt securities,
                                            and our failure continues for 90 days after we receive written notice of such failure, requiring
                                            the same to be remedied and stating that such is a notice of default thereunder, from the
                                            trustee or holders of at least 25% in aggregate principal amount of the outstanding debt
                                            securities of the applicable series; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            specified events of bankruptcy, insolvency or reorganization occur.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an event
of default with respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last
bullet point above, the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that
series, by notice to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal of, premium,
if any, and accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs
with respect to us, the principal amount of and accrued interest, if any, of each issue of debt securities then outstanding shall be
due and payable without any notice or other action on the part of the trustee or any holder.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders
of a majority in principal amount of the outstanding debt securities of an affected series may waive any default or event of default
with respect to the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any,
or interest, unless we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default
or event of default.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to
the terms of the indenture, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation
to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series
of debt securities, unless such holders have offered the trustee reasonable indemnity. The holders of a majority in principal amount
of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding
for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities
of that series, provided that:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            direction so given by the holder is not in conflict with any law or the applicable indenture;
                                            and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
                                            to its duties under the Trust Indenture Act, the trustee need not take any action that might
                                            involve it in personal liability or might be unduly prejudicial to the holders not involved
                                            in the proceeding.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A holder of
the debt securities of any series will have the right to institute a proceeding under the indenture or to appoint a receiver or trustee,
or to seek other remedies only if:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            holder has given written notice to the trustee of a continuing event of default with respect
                                            to that series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            holders of at least 25% in aggregate principal amount of the outstanding debt securities
                                            of that series have made written request;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            holders have offered to the trustee indemnity satisfactory to it against the costs, expenses
                                            and liabilities to be incurred by the trustee in compliance with the request; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            trustee does not institute the proceeding, and does not receive from the holders of a majority
                                            in aggregate principal amount of the outstanding debt securities of that series other conflicting
                                            directions within 90 days after the notice, request and offer.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These limitations
do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest
on, the debt securities.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will periodically
file statements with the trustee regarding our compliance with specified covenants in the indenture.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Modification of Indenture; Waiver</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We and the
trustee may change an indenture without the consent of any holders with respect to specific matters:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            cure any ambiguity, defect or inconsistency in the indenture or in the debt securities of
                                            any series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            comply with the provisions described above under &#8220;Description of Debt Securities&#8212;Consolidation,
                                            Merger or Sale;&#8221;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            provide for uncertificated debt securities in addition to or in place of certificated debt
                                            securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            add to our covenants, restrictions, conditions or provisions such new covenants, restrictions,
                                            conditions or provisions for the benefit of the holders of all or any series of debt securities,
                                            to make the occurrence, or the occurrence and the continuance, of a default in any such additional
                                            covenants, restrictions, conditions or provisions an event of default or to surrender any
                                            right or power conferred upon us in the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            add to, delete from or revise the conditions, limitations, and restrictions on the authorized
                                            amount, terms, or purposes of issue, authentication and delivery of debt securities, as set
                                            forth in the indenture;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            make any change that does not adversely affect the interests of any holder of debt securities
                                            of any series in any material respect;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            provide for the issuance of and establish the form and terms and conditions of the debt securities
                                            of any series as provided above under &#8220;Description of Debt Securities&#8212;General&#8221;
                                            to establish the form of any certifications required to be furnished pursuant to the terms
                                            of the indenture or any series of debt securities, or to add to the rights of the holders
                                            of any series of debt securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            evidence and provide for the acceptance of appointment under any indenture by a successor
                                            trustee; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            comply with any requirements of the SEC in connection with the qualification of any indenture
                                            under the Trust Indenture Act.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition,
under the indenture, the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent
of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected.
However, unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, we and the trustee
may make the following changes only with the consent of each holder of any outstanding debt securities affected:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extending
                                            the fixed maturity of any debt securities of any series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reducing
                                            the principal amount, reducing the rate of or extending the time of payment of interest,
                                            or reducing any premium payable upon the redemption of any series of any debt securities;
                                            or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reducing
                                            the percentage of debt securities, the holders of which are required to consent to any amendment,
                                            supplement, modification or waiver.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discharge</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each indenture
provides that we can elect to be discharged from our obligations with respect to one or more series of debt securities, except for specified
obligations, including obligations to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
                                            for payment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">register
                                            the transfer or exchange of debt securities of the series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">replace
                                            stolen, lost or mutilated debt securities of the series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pay
                                            principal of and premium and interest on any debt securities of the series;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
                                            paying agencies;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hold
                                            monies for payment in trust;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recover
                                            excess money held by the trustee;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compensate
                                            and indemnify the trustee; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appoint
                                            any successor trustee.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to
exercise our rights to be discharged, we must deposit with the trustee money or government obligations sufficient to pay all the principal
of, any premium, if any, and interest on, the debt securities of the series on the dates payments are due.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form, Exchange and Transfer</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will issue
the debt securities of each series only in fully registered form without coupons and, unless we provide otherwise in the applicable prospectus
supplement, in denominations of $1,000 and any integral multiple thereof. The indenture provides that we may issue debt securities of
a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository
Trust Company, or DTC, or another depositary named by us and identified in the applicable prospectus supplement with respect to that
series. To the extent the debt securities of a series are issued in global form and as book-entry, a description of terms relating to
any book-entry securities will be set forth in the applicable prospectus supplement.</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At the option
of the holder, subject to the terms of the indenture and the limitations applicable to global securities described in the applicable
prospectus supplement, the holder of the debt securities of any series can exchange the debt securities for other debt securities of
the same series, in any authorized denomination and of like tenor and aggregate principal amount.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to
the terms of the indenture and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders
of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of
transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at
the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder
presents for transfer or exchange, we will impose no service charge for any registration of transfer or exchange, but we may require
payment of any taxes or other governmental charges.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will name
in the applicable prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we
initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any
transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a
transfer agent in each place of payment for the debt securities of each series.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we elect
to redeem the debt securities of any series, we will not be required to:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue,
                                            register the transfer of, or exchange any debt securities of that series during a period
                                            beginning at the opening of business 15 days before the day of mailing of a notice of redemption
                                            of any debt securities that may be selected for redemption and ending at the close of business
                                            on the day of the mailing; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">register
                                            the transfer of or exchange any debt securities so selected for redemption, in whole or in
                                            part, except the unredeemed portion of any debt securities we are redeeming in part.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information Concerning the Trustee</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The trustee,
other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as
are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree
of care as a prudent person would exercise or use in the conduct of his or her own affairs. Subject to this provision, the trustee is
under no obligation to exercise any of the powers given it by the indenture at the request of any holder of debt securities unless it
is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Payment and Paying Agents</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless we otherwise
indicate in the applicable prospectus supplement, we will make payment of interest on any debt securities on any interest payment date
to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the
regular record date for the interest.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will
pay principal of and any premium and interest on the debt securities of a particular series at the office of the paying agents
designated by us, except that unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments
by check that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable
prospectus supplement, we will designate the corporate trust office of the trustee as our sole paying agent for payments with
respect to debt securities of each series. We will name in the applicable prospectus supplement any other paying agents that we
initially designate for the debt securities of a particular series.
We will maintain a paying agent in each place of payment for the debt securities of a particular series.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All money we
pay to a paying agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains
unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the
holder of the debt security thereafter may look only to us for payment thereof.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing Law</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The indenture
and the debt securities will be governed by and construed in accordance with the internal laws of the State of New York, except to the
extent that the Trust Indenture Act is applicable.</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF WARRANTS</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following
description, together with the additional information we may include in any applicable prospectus supplements, summarizes the material
terms and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates.
While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any
series of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement, the terms of
any warrants offered under that prospectus supplement may differ from the terms described below. Specific warrant agreements will contain
additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement, which includes
this prospectus.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General </B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may issue
warrants for the purchase of our common stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently
or together with common stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these securities.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will evidence
each series of warrants by warrant certificates that we will issue under a separate warrant agreement. We will enter into the warrant
agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating
to a particular series of warrants.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will describe
in the applicable prospectus supplement the terms of the series of warrants, including:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            offering price and aggregate number of warrants offered; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            currency for which the warrants may be purchased; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the designation and terms of the securities with which the warrants are issued
                                            and the number of warrants issued with each such security or each principal amount of such
                                            security; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the date on and after which the warrants and the related securities will be separately
                                            transferable; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of warrants to purchase debt securities, the principal amount of debt securities
                                            purchasable upon exercise of one warrant and the price at, and currency in which, this principal
                                            amount of debt securities may be purchased upon such exercise; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of warrants to purchase common stock or preferred stock, the number of shares of
                                            common stock or preferred stock, as the case may be, purchasable upon the exercise of one
                                            warrant and the price at which these shares may be purchased upon such exercise; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            effect of any merger, consolidation, sale or other disposition of our business on the warrant
                                            agreement and the warrants; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            terms of any rights to redeem or call the warrants; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            provisions for changes to or adjustments in the exercise price or number of securities issuable
                                            upon exercise of the warrants; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            periods during which, and places at which, the warrants are exercisable; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            manner of exercise; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            dates on which the right to exercise the warrants will commence and expire; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            manner in which the warrant agreement and warrants may be modified; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">federal
                                            income tax consequences of holding or exercising the warrants; </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            terms of the securities issuable upon exercise of the warrants; and </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other specific terms, preferences, rights or limitations of or restrictions on the warrants.</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_024" TITLE="PLAN OF DISTRIBUTION"></A>PLAN OF DISTRIBUTION</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may sell
the offered securities in and outside the United States (1)&nbsp;through underwriters or dealers, (2)&nbsp;directly to one or more purchasers,
including through a &#8220;registered direct&#8221; offering, including to a limited number of institutional purchasers, to a single
purchaser or to our affiliates and stockholders, (3)&nbsp;through agents or (4)&nbsp;through a combination of any of these methods or
otherwise.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If underwriters
or dealers are used in the sale, the securities will be acquired by the underwriters or dealers for their own account and may be resold
from time to time in one or more transactions, including:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            one or more transactions at a fixed price or prices, which may be changed from time to time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            &#8220;at-the-market offerings,&#8221; within the meaning of Rule 415(a)(4) of the Securities
                                            Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            a market maker or into an existing trading market on an exchange or otherwise;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            prices related to those prevailing market prices; or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            negotiated prices.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0 0 9pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The applicable
prospectus supplement will set forth the following information to the extent applicable:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            terms of the offering;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            names of any underwriters, dealers or agents or other purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            name or names of any managing underwriter or underwriters;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            purchase price of the securities or other purchasers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            net proceeds from the sale of the securities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            option to purchase additional shares or other options under which underwriters, dealers,
                                            agents or other purchasers may purchase additional securities from us;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            delayed delivery arrangements;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            underwriting discounts, commissions and other items constituting underwriters&#8217; compensation;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            initial public offering price;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            discounts or concessions allowed or reallowed or paid to dealers; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; margin-top: 0; margin-bottom: 9pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            commissions paid to agents.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale through Underwriters or
Dealers</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any securities
are offered through underwriters, the underwriters will acquire the securities for their own account and may resell them from time to
time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined
at the time of sale. Underwriters may offer and sell securities to the public either through underwriting syndicates represented by one
or more managing underwriters or directly by one or more firms acting as underwriters. Unless otherwise provided in the applicable prospectus
supplement, the obligations of the underwriters to purchase the securities will be subject to certain conditions, and the underwriters will be obligated
to purchase all of the offered securities if they purchase any of them. In connection with the sale of securities, underwriters may be
deemed to have received compensation from us in the form of underwriting discounts or commissions and dealers may receive compensation
from the underwriters in the form of discounts or concessions. The underwriters may change from time to time any initial public offering
price and any discounts or concessions allowed or reallowed or paid to dealers.</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to
facilitate the offering of securities, the underwriters may engage in transactions that stabilize, maintain or otherwise affect the price
of the securities. Specifically, the underwriters may overallot in connection with the offering, creating a short position in the securities
for their account. In addition, to cover overallotments or to stabilize the price of the shares, the underwriters may bid for, and purchase,
shares in the open market. Finally, an underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for
distributing the securities in the offering if the syndicate repurchases previously distributed shares in transactions to cover syndicate
short positions, in stabilization transactions, or otherwise. Any of these activities may stabilize or maintain the market price of the
offered securities above independent market levels. The underwriters are not required to engage in these activities, and may discontinue
any of these activities at any time.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some or all
of the securities that we offer through this prospectus may be new issues of securities with no established trading market. Any underwriters
to whom we sell securities for public offering and sale may make a market in those securities, but they will not be obligated to do so
and they may discontinue any market making at any time without notice. Accordingly, we cannot assure you of the liquidity of, or continued
trading markets for, any securities offered pursuant to this prospectus.</FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any securities
are offered through dealers, we will sell the securities to them as principal. They may then resell those securities to the public at
varying prices determined by the dealers at the time of resale.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Direct Sales and Sales through
Agents</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may sell
the securities directly to purchasers, including through one or more &#8220;registered direct&#8221; offerings. If the securities are
sold directly to institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with
respect to any sale of those securities, we will describe the terms of any such sales in the applicable prospectus supplement. We may
also sell the securities through agents designated from time to time. Sales may be made by means of ordinary brokers&#8217; transactions
on The Nasdaq Capital Market at market prices, in block transactions and such other transactions as agreed by us and any agent. In the
applicable prospectus supplement, we will name any agent involved in the offer or sale of the offered securities, and we will describe
any commissions payable to the agent. Unless otherwise provided in the applicable prospectus supplement, any agent will agree to use
its reasonable best efforts to solicit purchases for the period of its appointment.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>At-the-Market Offerings</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent
that we make sales through one or more underwriters or agents in&nbsp;at-the-market&nbsp;offerings, we will do so pursuant to the terms
of a sales agency financing agreement or other&nbsp;at-the-market&nbsp;offering arrangement between us, on one hand, and the underwriters
or agents, on the other. If we engage in&nbsp;at-the-market&nbsp;sales pursuant to any such agreement, we will issue and sell our securities
through one or more underwriters or agents, which may act on an agency basis or a principal basis. During the term of any such agreement,
we may sell securities on a daily basis in exchange transactions or otherwise as we agree with the underwriters or agents. Any such agreement
will provide that any securities sold will be sold at prices related to the then prevailing market prices for our securities. Therefore,
exact figures regarding proceeds that will be raised or commissions to be paid cannot be determined at this time. Pursuant to the terms
of the agreement, we may agree to sell, and the relevant underwriters or agents may agree to solicit offers to purchase
blocks of our common stock or other securities. The terms of any such agreement will be set forth in more detail in the applicable prospectus
supplement.</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt"></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remarketing Arrangements</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offered securities
may also be offered and sold, if we so indicate in the applicable prospectus supplement, in connection with a remarketing upon their
purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting
as principals for their own accounts or as our agents. Any remarketing firm will be identified and the terms of its agreements, if any,
with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters
of the offered securities under the Securities Act.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delayed Delivery Contracts</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we so indicate
in the applicable prospectus supplement, we may authorize agents, underwriters or dealers to solicit offers by certain institutions to
purchase securities from us pursuant to contracts providing for payment and delivery on a specified future date. The applicable prospectus
supplement will describe the conditions to those contracts and the commission payable for solicitation of those contracts.</FONT></P>

<P STYLE="margin: 0 0 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General Information</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may have
agreements with the agents, dealers, underwriters and remarketing firms to indemnify them against certain civil liabilities, including
liabilities under the Securities Act, or to contribute with respect to payments that the agents, dealers or underwriters may be required
to make. Agents, dealers, underwriters and remarketing firms may be customers of, engage in transactions with or perform services for
us in the ordinary course of their businesses.</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_025" TITLE="LEGAL MATTERS"></A>LEGAL MATTERS</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The validity
and enforceability of the securities offered hereby as to Nevada law will be passed upon for us by Stradling Yocca Carlson &amp; Rauth,
PC. The enforceability of the securities offered hereby as to New York law will be passed upon for us by Freshfields Bruckhaus Deringer
US LLP. Any underwriters or agents will be advised about other issues relating to the offering by counsel to be named in the applicable
prospectus supplement.</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_026" TITLE="EXPERTS"></A>EXPERTS</B></FONT></P>

<P STYLE="margin: 0 0 9pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated
financial statements of Expion360, Inc. as of December 31, 2022 and 2021, and for each of the two years in the period ended December
31, 2022&nbsp;&nbsp;, incorporated by reference in this Prospectus, have been audited by M&amp;K CPAS, PLLC, an independent registered
public accounting firm, as stated in their report. Such financial statements are incorporated by reference in reliance upon the report
of such firm given their authority as experts in accounting and auditing.</FONT></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0 0 9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_003.jpg" ALT="Icon&#10;&#10;Description automatically generated" STYLE="height: 84px; width: 80px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPION360 INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>100,000 Shares of Common Stock<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>May 7, 2024</B></P>

<!-- Field: Page; Sequence: 41; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !4 % # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#:^)/Q)FT"
MX.BZ*4^V[<SSD;O)ST ']['//2O(KKQ!K5[*9;G6+Z5R>K7#_P LXH\074E[
MXCU.YE8EY+N4G/\ O$#]*SZ!EK^U-2_Z"5Y_X$/_ (T?VIJ7_02O/_ A_P#&
MFV&G7NJ7:6EA:R7,[_=CC7)^OL/>NAU7X;^*-&T@ZG=6*F)>9$BD#O&/4@=O
MIG% &!_:FI?]!*\_\"'_ ,:/[4U+_H)7G_@0_P#C6QHWA)-;M!<6^L0\#]Y'
MY1WQGT(S^M7V^',X'R:K$3_M0G_&N>6)I1=I/4CGBCF/[4U+_H)7G_@0_P#C
M1_:FI?\ 02O/_ A_\:Z"?X>ZH@S#=VDQ]#N3^E<_J&EWVE2B.^MVA+?=)Y5O
MH1P:N%:G/X7<:DGL2V^OZS:2B6WU>^B<="MR_P#C7K'PW^)MQJ]XFB:ZRM<N
M/]'N0 OF$?PL.F?0]Z\8JSIEQ)::K9W,3;9(9T=2/4,#6I0NJ?\ (8OO^OF7
M_P!#-5,XYJWJG_(8OO\ KYE_]#-5E7>ZH>C,%_,T ?0/PZT&S\+>#$U*Y58[
MBYA^TW4S#E4QD+] /US7 :_\8M=OKN1=',=A:9PA,8>1AZDG(&?0"O6_$.C3
MZMX0NM&LY4AEGMQ"COG:O3KCGI7E7_"CM>_Z"NG?D_\ A0(\^34+R*]>]@N&
M@N')+2183.>O XQ[5:'B77E_YC%UQZN#_2NW_P"%':]_T%=._)_\*#\#M> /
M_$TTXGL,/S^E2XQ>Z"R9REKXVURVD#23I=)W25!S^(P17<(;'Q9H +)^YN!T
M;[T3C^H/^>:\]G\/7EEK;:/JC1Z;<@X!N =C>F&'8]CTKOO"^BW.A:?+:W,T
M<I>;S%\O.%& ._TKSL9&G!*4=)&-1);;GE\\,EO<2V\O$D3E&^H.*=;?\?</
M_71?YBM#Q2@C\4:@JC@R[OS /]:S[;_C[A_ZZ+_,5Z,7S13-D[HFU3_D,7W_
M %\R_P#H9JM&P25&/16!/YU9U3_D,7W_ %\R_P#H9JH0""#5#/ICQEJ-U8>!
MM0U'3IC#<16XDCD4 [>1S@\=*\1_X69XS_Z#LG_?F/\ ^)KV'P=J-GXR^'\5
MO.V\FW-I=H#\RL%VY_$8(^M>.^(?AWXBT&\DC%A->VP/[NYMT+AE[9 Y!]J!
M#3\2?&3')UZ?\(T'_LM)_P +'\8_]!Z?_OA/_B:PSINH*<-I]V#Z&!_\*3^S
MK\_\N%U_WX;_  H&7-8\3:SX@B2/5KYKM8SE-\:@K^(&:;;^(]:M8$@AU*9(
MD&%4X.!Z9(S4MAX2\1:E($M-%O7R<;FA**/J6P*]P\#>$H?"'A=EU7[.UP[-
M/<NP!6,8Z9/8 =?K4N,9;H329\^75S/>W+W-S(TDTA!=SU/&/Y"BV_X^X?\
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MKX<U^<Z?;V5WI]U(K&)S/YBD@9P:Y^!2E[$C##+*%(]PV#3C.[MU!.Y-JO\
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:8TGPO9&TTNV$8;F21CN>0^K-W_E110(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !4 % # 2(  A$! Q$!_\0
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M/<NP!6,8Z9/8 =?K4N,9;H329\^75S/>W+W-S(TDTA!=SU/&/Y"BV_X^X?\
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MKX<U^<Z?;V5WI]U(K&)S/YBD@9P:Y^!2E[$C##+*%(]PV#3C.[MU!.Y-JO\
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:8TGPO9&TTNV$8;F21CN>0^K-W_E110(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !4 % # 2(  A$! Q$!_\0
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M/<NP!6,8Z9/8 =?K4N,9;H329\^75S/>W+W-S(TDTA!=SU/&/Y"BV_X^X?\
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MKX<U^<Z?;V5WI]U(K&)S/YBD@9P:Y^!2E[$C##+*%(]PV#3C.[MU!.Y-JO\
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:8TGPO9&TTNV$8;F21CN>0^K-W_E110(__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
